These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
674 related articles for article (PubMed ID: 24343302)
1. Tumour-associated mutant p53 drives the Warburg effect. Zhang C; Liu J; Liang Y; Wu R; Zhao Y; Hong X; Lin M; Yu H; Liu L; Levine AJ; Hu W; Feng Z Nat Commun; 2013; 4():2935. PubMed ID: 24343302 [TBL] [Abstract][Full Text] [Related]
2. Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis. Zheng T; Wang J; Zhao Y; Zhang C; Lin M; Wang X; Yu H; Liu L; Feng Z; Hu W Nat Commun; 2013; 4():2996. PubMed ID: 24356649 [TBL] [Abstract][Full Text] [Related]
3. Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53. Zhao Y; Zhang C; Yue X; Li X; Liu J; Yu H; Belyi VA; Yang Q; Feng Z; Hu W Cell Death Differ; 2015 Nov; 22(11):1824-36. PubMed ID: 25857266 [TBL] [Abstract][Full Text] [Related]
4. Gain of function mutant p53 protein activates AKT through the Rac1 signaling to promote tumorigenesis. Yue X; Wu F; Li Y; Liu J; Boateng M; Mandava K; Zhang C; Feng Z; Gao J; Hu W Cell Cycle; 2020 Jun; 19(11):1338-1351. PubMed ID: 32275841 [TBL] [Abstract][Full Text] [Related]
5. Gain-of-function mutant p53 in cancer progression and therapy. Zhang C; Liu J; Xu D; Zhang T; Hu W; Feng Z J Mol Cell Biol; 2020 Sep; 12(9):674-687. PubMed ID: 32722796 [TBL] [Abstract][Full Text] [Related]
6. The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer. Liu J; Zhang C; Xu D; Zhang T; Chang CY; Wang J; Liu J; Zhang L; Haffty BG; Zong WX; Hu W; Feng Z J Clin Invest; 2023 Mar; 133(6):. PubMed ID: 36749630 [TBL] [Abstract][Full Text] [Related]
7. BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function. Yue X; Zhao Y; Liu J; Zhang C; Yu H; Wang J; Zheng T; Liu L; Li J; Feng Z; Hu W Elife; 2015 Aug; 4():. PubMed ID: 26271008 [TBL] [Abstract][Full Text] [Related]
8. Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells. Ghaleb A; Padellan M; Marchenko N Breast Cancer Res; 2020 Dec; 22(1):133. PubMed ID: 33267874 [TBL] [Abstract][Full Text] [Related]
10. Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome. Zhang Y; Hu Y; Fang JY; Xu J Oncotarget; 2016 Mar; 7(10):11056-66. PubMed ID: 26840456 [TBL] [Abstract][Full Text] [Related]
11. Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation. Kong LR; Ong RW; Tan TZ; Mohamed Salleh NAB; Thangavelu M; Chan JV; Koh LYJ; Periyasamy G; Lau JA; Le TBU; Wang L; Lee M; Kannan S; Verma CS; Lim CM; Chng WJ; Lane DP; Venkitaraman A; Hung HT; Cheok CF; Goh BC Nat Commun; 2020 Apr; 11(1):2086. PubMed ID: 32350249 [TBL] [Abstract][Full Text] [Related]
12. Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment. Alexandrova EM; Yallowitz AR; Li D; Xu S; Schulz R; Proia DA; Lozano G; Dobbelstein M; Moll UM Nature; 2015 Jul; 523(7560):352-6. PubMed ID: 26009011 [TBL] [Abstract][Full Text] [Related]
13. Tumor-associated mutant p53 promotes cancer cell survival upon glutamine deprivation through p21 induction. Tran TQ; Lowman XH; Reid MA; Mendez-Dorantes C; Pan M; Yang Y; Kong M Oncogene; 2017 Apr; 36(14):1991-2001. PubMed ID: 27721412 [TBL] [Abstract][Full Text] [Related]
15. Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches. Alvarado-Ortiz E; de la Cruz-López KG; Becerril-Rico J; Sarabia-Sánchez MA; Ortiz-Sánchez E; García-Carrancá A Front Cell Dev Biol; 2020; 8():607670. PubMed ID: 33644030 [TBL] [Abstract][Full Text] [Related]
17. Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy. Yue X; Zhao Y; Xu Y; Zheng M; Feng Z; Hu W J Mol Biol; 2017 Jun; 429(11):1595-1606. PubMed ID: 28390900 [TBL] [Abstract][Full Text] [Related]
18. Proteasomal and autophagy-mediated degradation of mutp53 proteins through mitochondria-targeting aggregation-induced-emission materials. Wang M; Yang Z; Song Y; Wei P; Ishiwme N; Wang L; Zhang H; Jing M; Gao M; Wen L; Zhang Y Acta Biomater; 2022 Sep; 150():402-412. PubMed ID: 35931280 [TBL] [Abstract][Full Text] [Related]
19. Yin Yang 1 promotes the Warburg effect and tumorigenesis via glucose transporter GLUT3. Wang Y; Wu S; Huang C; Li Y; Zhao H; Kasim V Cancer Sci; 2018 Aug; 109(8):2423-2434. PubMed ID: 29869834 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and Invasion. Schulz-Heddergott R; Stark N; Edmunds SJ; Li J; Conradi LC; Bohnenberger H; Ceteci F; Greten FR; Dobbelstein M; Moll UM Cancer Cell; 2018 Aug; 34(2):298-314.e7. PubMed ID: 30107178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]